aabb-logo-sm

Advocacy

US Capitol

View the AABB Advocacy Agenda

 

Read More

AABB educates policymakers, and develops and advances legislative, regulatory and other policy solutions intended to ensure that patients have access to safe blood transfusions and biotherapies. The Association develops proactive policy solutions and responds to proposals that impact the transfusion medicine and biotherapies community.

Advocacy Priorities & Positions

Promoting Blood System Sustainability Supporting Patient & Donor Care and Safety Advancing Cellular Therapies & Biotherapies Improving Coverage & Reimbursement Policies

Comments to FDA

AABB provides feedback on draft guidances, proposed regulations and potential research priorities relevant to transfusion medicine and cellular therapies.

View More

FDA Sign

Additional Resources

Partner With AABB

AABB collaborates with other membership organizations, professional societies and patient advocacy groups to create strategic alliances that engage elected officials to create meaningful change for donors and patients.

Let's Collaborate

Become an Advocate

AABB is an unrelenting advocate for policies that advance the safety and availability blood, blood components and cellular therapies.

Join Us

AABB Advocacy Staff

LEAH MENDELSOHN STONE
Vice President, Public Policy & Advocacy
Lmstone@aabb.org
301.215.6554

SUSAN N. LEPPKE
Senior Director, Public Policy & Strategic Partnerships
Sleppke@aabb.org
301.547.3962

Contact us at advocacy@aabb.org